Chapter 4 - Immune Checkpoint Inhibitors

Victoria Sherry
Susan Stonehouse-Lee

Chapter 4 examines immune checkpoint inhibitors, including checkpoint receptors such as Cytotoxic T-lymphocyte Antigen 4 and programmed cell death protein 1 and its ligands, and checkpoint inhibitors such as anti–CTLA-4 agents and anti–PD-1 agents. Also included are details surrounding nursing administration managing adverse events such as dermatologic toxicities, diarrhea and colitis, and pneumonitis.

Price: $12.95